Susquehanna International Group, LLP Applied Genetic Technologies Corp Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $1,316 - $4,039	-4,539 Reduced 18.12%	20,512 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.1 $292 - $519	-472 Reduced 1.85%	25,051 $19,000
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $57,055 - $144,505	-53,323 Reduced 67.63%	25,523 $27,000
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $32,240 - $50,171	-17,241 Reduced 17.94%	78,846 $149,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $324,225 - $443,789	-107,716 Reduced 52.85%	96,087 $289,000
Q2 2021 Aug 11, 2021	BUY	$3.62 - $5.23 $435,073 - $628,572	120,186 Added 143.73%	203,803 $797,000
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $179,959 - $374,078	45,675 Added 120.38%	83,617 $424,000
Q1 2020 May 15, 2020	BUY	$2.36 - $9.86 $14,551 - $60,796	6,166 Added 19.4%	37,942 $124,000
Q4 2019 Feb 14, 2020	SELL	$2.69 - $4.92 $37,412 - $68,427	-13,908 Reduced 30.44%	31,776 $144,000
Q4 2018 Feb 14, 2019	BUY	$2.28 - $7.15 $73,388 - $230,144	32,188 Added 238.5%	45,684 $114,000
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $10,312 - $12,586	-3,033 Reduced 18.35%	13,496 $49,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $58,677 - $86,777	16,529	16,529 $65,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.